IIA
VRNA

IPG Investment Advisors’s Verona Pharma VRNA Stock Holding History

IPG Investment Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,900
Closed -$50K – 180
2022
Q2 		$50K Hold
11,900
– – 0.01% 143
2022
Q1 		$59K Hold
11,900
– – 0.01% 160
2021
Q4 		$80K Buy
+11,900
New +$60.8K 0.01% 193

Other funds holding VRNA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

IPG Investment Advisors's VRNA Position: Q3 2022 in Review

IPG Investment Advisors sold out of Verona Pharma (VRNA) in Q3 2022, closing a stake of 11,900 shares — an estimated $50K sold.

IPG Investment Advisors first reported a position in VRNA in Q4 2021 and held it in 3 quarters. The position peaked at $80K in Q4 2021. 68 funds tracked by Wall St. Rank hold VRNA as of Q3 2022.

  • IPG Investment Advisors reported no remaining Verona Pharma position as of Q3 2022 after selling out during the quarter.
  • IPG Investment Advisors sold 11,900 Verona Pharma shares in Q3 2022, an estimated $50K.
  • IPG Investment Advisors first reported a position in Verona Pharma in Q4 2021 and held it in 3 quarters.
  • IPG Investment Advisors's Verona Pharma position peaked at $80K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2022.

Based on IPG Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.